Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for ...

A new prototype photodynamic therapy (PDT) device that can be used at home significantly reduces pain levels during treatment of basal cell carcinoma (BCC), while achieving efficacy comparable with a ...

Combination of near-infrared light and aquatic photosensitizer clears early-stage disease in half of men treated in major European trial. A large clinical trial across 47 European hospitals has shown ...

Prognostic factors in elderly patients with grade 3 gliomas. Background: Usual treatment of brain tumors includes surgery, radiotherapy and chemotherapy, but the general prognosis is bad, with local ...

Maksim Abakumov, head of the NUST MISIS Biomedical Nanomaterials laboratory, and colleagues hope to improve the effectiveness of photodynamic therapy. (Courtesy: NUST MISIS) Photodynamic therapy (PDT) ...

WOBURN, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...

Analysis of four human PlGF isoforms and of VEGFR-1 in esophageal carcinoma. Background: FDA approved PDT with porfimer sodium has been explored to treat lesions associated with Barrett's esophagus.

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...

Study results expected to form the basis of a supplemental New Drug Application (sNDA) planned for submission in Q2 2026 WOBURN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: ...

Please provide your email address to receive an email when new articles are posted on . A portable photodynamic therapy device for at-home treatment of basal cell carcinoma was shown to be efficacious ...